Jinghe Li

1.3k total citations
58 papers, 976 citations indexed

About

Jinghe Li is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Jinghe Li has authored 58 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 19 papers in Oncology and 11 papers in Surgery. Recurrent topics in Jinghe Li's work include Cancer-related gene regulation (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers) and Peptidase Inhibition and Analysis (8 papers). Jinghe Li is often cited by papers focused on Cancer-related gene regulation (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers) and Peptidase Inhibition and Analysis (8 papers). Jinghe Li collaborates with scholars based in China, United States and Japan. Jinghe Li's co-authors include Senlin Chen, Lufeng Liang, Qiong Zou, Zhulin Yang, Jifang Wen, Xiongying Miao, Meigui Chen, Gengqiu Luo, Weiyuan Wang and Yuan Yuan and has published in prestigious journals such as PLoS ONE, Diabetes and IEEE Transactions on Geoscience and Remote Sensing.

In The Last Decade

Jinghe Li

56 papers receiving 966 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinghe Li China 20 511 269 232 141 131 58 976
Qifeng Luo China 19 790 1.5× 201 0.7× 581 2.5× 54 0.4× 101 0.8× 53 1.1k
Xiongfei Yu China 15 455 0.9× 279 1.0× 306 1.3× 106 0.8× 164 1.3× 33 972
Ronghua Wang China 16 519 1.0× 382 1.4× 279 1.2× 106 0.8× 83 0.6× 43 950
Jianming Zheng China 22 627 1.2× 378 1.4× 452 1.9× 137 1.0× 166 1.3× 86 1.5k
Yasuhisa Yokoyama Japan 19 401 0.8× 185 0.7× 130 0.6× 301 2.1× 135 1.0× 108 1.2k
Kazuki Okamura Japan 16 619 1.2× 126 0.5× 233 1.0× 71 0.5× 61 0.5× 60 1.2k
Xingxing Yu China 15 365 0.7× 295 1.1× 247 1.1× 330 2.3× 292 2.2× 54 1.0k
Yuqiang Ji China 15 405 0.8× 179 0.7× 274 1.2× 256 1.8× 37 0.3× 46 883
Na Che China 22 952 1.9× 430 1.6× 536 2.3× 134 1.0× 169 1.3× 59 1.5k
Yu Mao China 21 563 1.1× 141 0.5× 379 1.6× 149 1.1× 143 1.1× 41 1.1k

Countries citing papers authored by Jinghe Li

Since Specialization
Citations

This map shows the geographic impact of Jinghe Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinghe Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinghe Li more than expected).

Fields of papers citing papers by Jinghe Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinghe Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinghe Li. The network helps show where Jinghe Li may publish in the future.

Co-authorship network of co-authors of Jinghe Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jinghe Li. A scholar is included among the top collaborators of Jinghe Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinghe Li. Jinghe Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jinghe, et al.. (2024). Metabolic reprogramming directed by super-enhancers in tumors: An emerging landscape. Molecular Therapy. 32(3). 572–579. 10 indexed citations
2.
Li, Yidan, et al.. (2023). Emerging role of ferroptosis-related circular RNA in tumor metastasis. Frontiers in Pharmacology. 14. 1168458–1168458. 4 indexed citations
3.
Zhang, Junfeng, Jiali Yang, Qiang Zhou, et al.. (2023). The role of histone H1.2 in pancreatic cancer metastasis and chemoresistance. Drug Resistance Updates. 73. 101027–101027. 5 indexed citations
4.
Jiang, Zhongyi, Jing Zhou, Ruifeng Wang, et al.. (2023). Emerging roles of ferroptosis-related miRNAs in tumor metastasis. Cell Death Discovery. 9(1). 193–193. 16 indexed citations
5.
Li, Jinghe, Wang Zuo, Yufei Zhao, et al.. (2020). In vitro high-throughput drug sensitivity screening with patient-derived primary cells as a guide for clinical practice in hepatocellular carcinoma—A retrospective evaluation. Clinics and Research in Hepatology and Gastroenterology. 44(5). 699–710. 4 indexed citations
6.
Peng, Luyuan, Haitao Shi, Meng Yuan, et al.. (2020). Madecassoside Protects Against LPS-Induced Acute Lung Injury via Inhibiting TLR4/NF-κB Activation and Blood-Air Barrier Permeability. Frontiers in Pharmacology. 11. 807–807. 20 indexed citations
7.
Wang, Qunwei, Zhulin Yang, Qiong Zou, et al.. (2016). SHP2 and UGP2 are Biomarkers for Progression and Poor Prognosis of Gallbladder Cancer. Cancer Investigation. 34(6). 255–264. 21 indexed citations
8.
Wang, Junpu, Wanming Hu, Kuansong Wang, et al.. (2016). Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil. International Journal of Oncology. 48(4). 1341–1352. 55 indexed citations
9.
Zhang, Danhua, Zhulin Yang, Enxiang Zhou, et al.. (2016). Overexpression of Thy1 and ITGA6 is associated with invasion, metastasis and poor prognosis in human gallbladder carcinoma. Oncology Letters. 12(6). 5136–5144. 31 indexed citations
10.
Liu, Luyao, Zhulin Yang, Chunwei Wang, et al.. (2015). The Expression of Notch 1 and Notch 3 in Gallbladder Cancer and Their Clinicopathological Significance. Pathology & Oncology Research. 22(3). 483–492. 21 indexed citations
11.
Li, Jiao, Qiuyuan Wen, Lina Xu, et al.. (2014). Fatty acid synthase–associated protein with death domain: a prognostic factor for survival in patients with nasopharyngeal carcinoma. Human Pathology. 45(12). 2447–2452. 12 indexed citations
12.
Liu, Ziru, Zhulin Yang, Dong-cai Liu, et al.. (2014). TSG101 and PEG10 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder. Oncology Letters. 7(4). 1128–1138. 19 indexed citations
13.
Jia, Jiaoyuan, Mei Yang, Yu Chen, et al.. (2014). Inducing apoptosis effect of caffeic acid 3,4-dihydroxy-phenethyl ester on the breast cancer cells. Tumor Biology. 35(12). 11781–11789. 7 indexed citations
14.
15.
Yang, Zhulin, Xiongying Miao, Qiong Zou, et al.. (2014). ATP5b and β2-microglobulin are predictive markers for the prognosis of patients with gallbladder cancer. Journal of Molecular Histology. 46(1). 57–65. 24 indexed citations
16.
Yang, Zhulin, Xiongying Miao, Li Xiong, et al.. (2013). CFL1 and Arp3 are Biomarkers for Metastasis and Poor Prognosis of Squamous Cell/Adenosquamous Carcinomas and Adenocarcinomas of Gallbladder. Cancer Investigation. 31(2). 132–139. 46 indexed citations
17.
Deng, Zhenghao, Jifang Wen, Jinghe Li, Desheng Xiao, & Jianhua Zhou. (2008). Activator protein-1 involved in growth inhibition by RASSF1A gene in the human gastric carcinoma cell line SGC7901. World Journal of Gastroenterology. 14(9). 1437–1437. 9 indexed citations
18.
Li, Jinghe. (2008). The expression of Tiam 1 in thyroid carcinoma and its clinical significance. Zhongguo redai yixue. 1 indexed citations
19.
Xiao, Desheng, Jifang Wen, Jinghe Li, et al.. (2006). Effect of DPC4 Gene on Invasion and Metastasis of Colorectal Carcinoma Cells. Acta Biochimica et Biophysica Sinica. 38(12). 883–892. 8 indexed citations
20.
Wang, Kuan-Song, Zhongliang Hu, Jinghe Li, Desheng Xiao, & Jifang Wen. (2006). Enhancement of Metastatic and Invasive Capacity of Gastric Cancer Cells by Transforming Growth Factor-β1. Acta Biochimica et Biophysica Sinica. 38(3). 179–186. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qifeng Luo Breakdown of academic impact, for papers by Xiongfei Yu Breakdown of academic impact, for papers by Ronghua Wang Breakdown of academic impact, for papers by Jianming Zheng Breakdown of academic impact, for papers by Yasuhisa Yokoyama Breakdown of academic impact, for papers by Kazuki Okamura Breakdown of academic impact, for papers by Xingxing Yu Breakdown of academic impact, for papers by Yuqiang Ji Breakdown of academic impact, for papers by Na Che Breakdown of academic impact, for papers by Yu Mao
Rankless by CCL
2026